Y-mAbs Therapeutics | 4:持股变动声明-高管 Kruse Bo
Y-mAbs Therapeutics | 4:持股变动声明-高管 Gad Thomas
Y-mAbs Therapeutics | SC 13G:超过5%持股股东披露文件
Y-mAbs Therapeutics | 4:持股变动声明-董事 TAGLIAFERRI MARY
Y-mAbs Therapeutics | 3:首次持股声明-董事 TAGLIAFERRI MARY
Y-mAbs Therapeutics | 4:持股变动声明-高管 Gad Thomas
Y-mAbs Therapeutics | 4:持股变动声明-高管 Rajah Vignesh
Y-mAbs Therapeutics | 4:持股变动声明-高管 Smith Susan Laura
Y-mAbs Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
Y-mAbs Therapeutics | 4:持股变动声明-高管 Rossi Michael J
Y-mAbs Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.14%)
Y-mAbs Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-HBM Healthcare Investments (Cayman) Ltd.(7.6%)
Y-mAbs Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Anders Hove(6.3%),Acorn Bioventures 2 L.P.(3.7%)等
Y-mAbs Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(6.7%)
Y-mAbs Therapeutics | 4:持股变动声明-高管 Rajah Vignesh
Y-mAbs Therapeutics | 4:持股变动声明-高管 Smith Susan Laura
Y-mAbs Therapeutics | 4:持股变动声明-高管 Lisby Steen
Y-mAbs Therapeutics | 4:持股变动声明-高管 Wilms Joris
Y-mAbs Therapeutics | 4:持股变动声明-高管 Lund-Hansen Torben
Y-mAbs Therapeutics | 4:持股变动声明-高管 Gad Thomas
暂无数据